BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 7, 2015
View Archived Issues
FDA advisory committees on the decline, results vary
It's been three years since the FDA Safety and Innovation Act, the most recent reauthorization of the user fee program, was enacted, providing plenty of data on advisory committee meetings to examine.
Read More
Week in review
Read More
Word on the street
Read More
Week in Washington
Read More
Public financing of biotechnology companies: Commenced trading in November 2015
Read More
Biotech money raised by month in 2015
Read More
Public financing of biotechnology companies: Filed and pending IPOs
Read More
2015 top private financings of public companies
Read More
Other financings of public biotechnology companies: November 2015
Read More
2015 top financings of private companies
Read More
Venture capital & other investments in private biotechnology companies: November 2015
Read More
Milestone payments from corporate partners: November 2015
Read More
Money raised by biotech in 2015 vs. 2014
Read More
Money raised by biotech: Jan. 1 - Dec. 3, 2015
Read More
Nasdaq Stock Index 2015
Read More
The week's biggest gainers and losers
Read More
BioWorld Stock Index 2015
Read More
BioWorld stock report for public biotechnology companies
Read More
